Edition:
United States

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

1.95USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,025
52-wk High
$5.25
52-wk Low
$1.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.10 December 14 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 2 2 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.67 1.67 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 9.27 9.90 9.00 13.10
Quarter Ending Mar-18 3 9.29 10.20 8.20 --
Year Ending Dec-17 4 30.78 31.80 30.17 39.87
Year Ending Dec-18 4 41.12 48.50 37.43 68.33
Earnings (per share)
Quarter Ending Dec-17 4 -0.10 -0.10 -0.12 -0.07
Quarter Ending Mar-18 2 -0.10 -0.08 -0.12 --
Year Ending Dec-17 3 -0.86 -0.82 -0.90 -0.54
Year Ending Dec-18 4 -0.28 -0.05 -0.41 0.36

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 7.91 8.03 0.11 1.45
Quarter Ending Jun-17 7.97 6.60 1.36 17.10
Quarter Ending Mar-17 7.60 6.97 0.63 8.34
Quarter Ending Dec-16 7.10 7.23 0.13 1.83
Quarter Ending Sep-16 6.93 6.75 0.18 2.53
Earnings (per share)
Quarter Ending Sep-17 -0.12 -0.15 0.03 -21.65
Quarter Ending Jun-17 -0.15 -0.16 0.01 -6.67
Quarter Ending Mar-17 -0.18 -0.51 0.33 -183.33
Quarter Ending Dec-16 -0.22 -0.15 0.06 -30.23
Quarter Ending Sep-16 -0.28 -0.23 0.05 -16.36

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 9.27 9.32 9.32 9.47 13.10
Quarter Ending Mar-18 9.29 9.83 9.83 9.83 --
Year Ending Dec-17 30.78 30.81 30.81 30.81 39.87
Year Ending Dec-18 41.12 42.35 42.35 42.35 68.33
Earnings (per share)
Quarter Ending Dec-17 -0.10 -0.10 -0.10 -0.10 -0.07
Quarter Ending Mar-18 -0.10 -0.10 -0.10 -0.10 --
Year Ending Dec-17 -0.86 -0.86 -0.86 -0.86 -0.54
Year Ending Dec-18 -0.28 -0.26 -0.26 -0.26 0.36

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 1 0
Year Ending Dec-18 0 0 1 0
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 1 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0